Plasma Circulating Tumor DNA in Patients with Primary Central Nervous System Lymphoma

PURPOSE: Analysis of circulating tumor DNA (ctDNA) in blood could allow noninvasive genetic analysis of primary tumors. Although there have been unmet needs for noninvasive methods in patients with primary central nervous system lymphoma (PCNSL), it is still not determined whether plasma ctDNA analy...

Descripción completa

Detalles Bibliográficos
Autores principales: Yoon, Sang Eun, Kim, Yeon Jeong, Shim, Joon Ho, Park, Donghyun, Cho, Junhun, Ko, Young Hyeh, Park, Woong-Yang, Mun, Yeung-Chul, Lee, Kyoung Eun, Cho, Duck, Kim, Won Seog, Kim, Seok Jin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Korean Cancer Association 2022
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9016302/
https://www.ncbi.nlm.nih.gov/pubmed/34325497
http://dx.doi.org/10.4143/crt.2021.752

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9016302/
https://www.ncbi.nlm.nih.gov/pubmed/34325497
http://dx.doi.org/10.4143/crt.2021.752

Ejemplares similares